REQUEST A DEMO
Total
USD $0.00
Search more companies

Xanum C.L. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Medicinal and Botanical Manufacturing
Full name: Xanum C.L. Profile Updated: April 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Xanum C.L. is an enterprise in Ecuador, with the main office in Guayaquil. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on September 01, 2017. It currently has a total number of 4 (2021) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 321.84% in 2023. Its’ total assets recorded a negative growth of 15.18%. In 2023, Xanum C.L.’s net profit margin increased by 18.01%.

Headquarters
Av. del Ejercito 402
Guayaquil; Guayas;

Contact Details: Purchase the Xanum C.L. report to view the information.

Basic Information
Total Employees:
Purchase the Xanum C.L. report to view the information.
Outstanding Shares:
Purchase the Xanum C.L. report to view the information.
Registered Capital:
Purchase the Xanum C.L. report to view the information.
Incorporation Date:
September 01, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.75%
Purchase this report to view the information.
0.25%
Company Performance
Financial values in the chart are available after Xanum C.L. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
321.84%
Total operating revenue
321.84%
Operating profit (EBIT)
978.66%
EBITDA
559.44%
Net Profit (Loss) for the Period
10737.61%
Total assets
-15.18%
Total equity
75.63%
Operating Profit Margin (ROS)
14.34%
Net Profit Margin
18.01%
Return on Equity (ROE)
42.36%
Debt to Equity Ratio
-36.29%
Quick Ratio
0.92%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?